August 30, 2024Open Access
Ver artículo completoThe Effect of Semaglutide on Mortality and COVID-19–Related Deaths
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Patients with overweight and obesity are at increased risk of death from multiple causes, including cardiovascular (CV) death, with few therapies proven to reduce the risk.
Cite This Study
Scirica et al. (Fri,) studied this question.